| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,171 |
8,817 |
$1.02M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
9,898 |
6,713 |
$665K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,724 |
3,119 |
$277K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,432 |
1,913 |
$259K |
| G0378 |
Hospital observation service, per hour |
2,058 |
1,287 |
$180K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,205 |
8,486 |
$178K |
| A0425 |
Ground mileage, per statute mile |
23,516 |
13,127 |
$136K |
| 71045 |
Radiologic examination, chest; single view |
6,313 |
4,855 |
$122K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,498 |
1,058 |
$92K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,597 |
19,515 |
$86K |
| 86480 |
|
1,245 |
1,157 |
$84K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,420 |
1,167 |
$73K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
11,111 |
5,808 |
$60K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,395 |
1,278 |
$59K |
| 80053 |
Comprehensive metabolic panel |
12,723 |
9,904 |
$56K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,144 |
2,476 |
$49K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
34,800 |
26,639 |
$48K |
| 84484 |
|
6,273 |
4,095 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,584 |
1,289 |
$41K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,189 |
6,733 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,188 |
1,192 |
$30K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
808 |
645 |
$30K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
331 |
285 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,239 |
916 |
$23K |
| 99218 |
|
214 |
149 |
$23K |
| 83880 |
|
1,095 |
881 |
$22K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,391 |
1,277 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,081 |
520 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
764 |
653 |
$18K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
657 |
615 |
$17K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,478 |
2,976 |
$16K |
| 83735 |
|
5,738 |
3,587 |
$15K |
| 85730 |
|
4,461 |
3,438 |
$14K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
111 |
92 |
$13K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
428 |
243 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
498 |
367 |
$13K |
| 84703 |
|
2,284 |
1,737 |
$11K |
| 83690 |
|
2,528 |
1,978 |
$11K |
| 85610 |
|
5,782 |
4,165 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,379 |
1,222 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
245 |
132 |
$10K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
419 |
372 |
$10K |
| 80061 |
Lipid panel |
3,541 |
3,032 |
$9K |
| 93017 |
|
239 |
225 |
$7K |
| 81001 |
|
5,798 |
4,703 |
$7K |
| 87040 |
|
1,192 |
672 |
$6K |
| 82962 |
|
5,246 |
1,984 |
$6K |
| 83605 |
|
1,228 |
922 |
$6K |
| 87631 |
|
306 |
261 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,420 |
2,079 |
$6K |
| 87077 |
|
1,976 |
1,462 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,366 |
2,682 |
$6K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
654 |
435 |
$5K |
| 87186 |
|
1,341 |
1,022 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
11,481 |
7,508 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,094 |
926 |
$4K |
| 84439 |
|
1,685 |
1,489 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
54 |
52 |
$3K |
| 87088 |
|
1,249 |
1,055 |
$3K |
| 85027 |
|
1,542 |
1,216 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
116 |
$3K |
| 83655 |
|
1,336 |
874 |
$3K |
| 82607 |
|
525 |
440 |
$3K |
| 96376 |
|
493 |
245 |
$2K |
| 87070 |
|
693 |
593 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
430 |
366 |
$2K |
| 71250 |
|
25 |
24 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
12 |
$2K |
| 82947 |
|
1,188 |
391 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
3,278 |
2,478 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,678 |
2,314 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
256 |
125 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,324 |
1,558 |
$1K |
| 77080 |
|
12 |
12 |
$1K |
| 85014 |
|
1,145 |
915 |
$977.57 |
| 86140 |
|
570 |
493 |
$846.30 |
| 80050 |
General health panel |
257 |
237 |
$816.28 |
| 80076 |
|
217 |
189 |
$773.56 |
| 71271 |
|
27 |
26 |
$746.40 |
| 85018 |
|
941 |
744 |
$697.91 |
| 82565 |
|
284 |
241 |
$639.38 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14 |
12 |
$627.97 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
17 |
14 |
$559.36 |
| 87205 |
|
337 |
287 |
$533.27 |
| 84145 |
|
548 |
425 |
$525.06 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,245 |
2,387 |
$433.59 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
29 |
26 |
$432.64 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,317 |
726 |
$428.05 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,842 |
3,274 |
$404.52 |
| 87081 |
|
237 |
224 |
$393.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,176 |
781 |
$330.08 |
| 85652 |
|
460 |
403 |
$328.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
825 |
670 |
$325.65 |
| 82043 |
|
119 |
103 |
$274.04 |
| 82746 |
|
67 |
54 |
$231.20 |
| 82728 |
|
82 |
79 |
$231.04 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
617 |
340 |
$225.19 |
| 83540 |
|
157 |
142 |
$217.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,727 |
1,283 |
$189.87 |
| 86850 |
|
28 |
24 |
$162.64 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,318 |
1,767 |
$122.11 |
| 82550 |
|
56 |
39 |
$118.53 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
50 |
26 |
$112.20 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
340 |
94 |
$104.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
142 |
102 |
$97.48 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,017 |
477 |
$95.18 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
226 |
200 |
$81.68 |
| C1769 |
Guide wire |
289 |
226 |
$66.46 |
| J1815 |
Injection, insulin, per 5 units |
312 |
69 |
$57.97 |
| 83550 |
|
33 |
31 |
$50.52 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
585 |
322 |
$46.31 |
| 87252 |
|
27 |
12 |
$45.10 |
| 76937 |
|
15 |
13 |
$37.28 |
| 86038 |
|
13 |
13 |
$26.44 |
| 86901 |
|
28 |
24 |
$25.40 |
| 86039 |
|
13 |
12 |
$21.64 |
| 93356 |
|
14 |
12 |
$19.97 |
| 86900 |
|
28 |
24 |
$14.77 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
12 |
$12.72 |
| J7999 |
Compounded drug, not otherwise classified |
149 |
93 |
$9.14 |
| 84132 |
|
15 |
12 |
$6.92 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
13 |
12 |
$3.67 |
| A9270 |
Non-covered item or service |
5,621 |
1,926 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
84 |
48 |
$0.00 |
| 88342 |
|
15 |
12 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
41 |
40 |
$0.00 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
49 |
39 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
38 |
25 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
42 |
26 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
47 |
40 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
14 |
14 |
$0.00 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
12 |
$0.00 |